Risk of neoplasm with the neurokinin 3 receptor antagonist fezolinetant
Jonathan Douxfils, Charlotte Beaudart, Jean‐Michel Dogné
Topics & Concepts
AntagonistMedicineTachykinin receptor 1Internal medicinePharmacologyReceptorNeuropeptideSubstance PEstrogen and related hormone effectsMenopause: Health Impacts and TreatmentsPituitary Gland Disorders and Treatments